Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant

Journal of Clinical Pharmacy and Therapeutics

Volumn 31, Issue 1, 2006, Pages 27-34

  Pawinski, T ^a   Durlik, M ^a   Szlaska, I ^a   Urbanowicz, A ^a   Majchrnak, J ^a   Gralak, B ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Immunosuppressive agents; Mycophenolic acid; Pharmacokinetics; Receiver operating characteristic curve analysis; Renal transplant

Indexed keywords

CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TSUKUBAENOLIDE;

ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; DRUG SAFETY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; VALIDATION PROCESS;

ADOLESCENT; ADULT; AREA UNDER CURVE; CREATININE; CYCLOSPORINE; FEMALE; GLUCURONIDES; GRAFT REJECTION; HEMATOCRIT; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; TACROLIMUS; TIME FACTORS;

EID: 33645123973     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2006.00713.x     Document Type: Article

References (29)

1. Shaw LM Pawinski T Korecka M Nawrocki A 2002 Monitoring of mycophenolic acid in clinical transplantation Therapeutic Drug Monitoring 24 68 73
2. Shaw LM Korecka M Venkataramanan R Goldberg L Bloom R Brayman KL 2003 Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies American Journal of Transplantation 3 534 542
3. Offermann G 2003 Five-year results of renal transplantation on immunosuppressive triple therapy with mycophenolate mofetil Clinical Transplantation 17 43 46
4. Wallemacq PE 2004 Therapeutic monitoring of immunosuppressant drugs. Where are we Clinical Chemistry and Laboratory Medicine 42 1204 1211
5. Cox VC Ensom MHH 2003 Mycophenolate mofetil for solid organ transplantation: does the evidence support the need for clinical pharmacokinetic monitoring Therapeutic Drug Monitoring 25 137 157
6. Hale MD Nicholls AJ Bullingham RES et al. 1998 The pharmacokinetic- pharmacodynamic relationship for mycophenolate mofetil in renal transplantation Clinical Pharmacology and Therapy 64 672 683
7. van Gelder T Hilbrands LB Vanrenterghem Y et al. 1999 A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation Transplantation 68 261 266
8. Nicholls AJ 1998 Opportunities for therapeutic monitoring of mycophenolate mofetil dose in renal transplantation suggested by the pharmacokinetic/pharmacodynamic relationship for mycophenolic acid and suppression of rejection Clinical Biochemistry 31 329 333
9. Weber LT Shipkova M Armstrong VW et al. 2002 Comparison of the Emit immunoassay with HPLC for therapeutic drug monitoring of mycophenolic acid in pediatric renal-transplant recipients on mycophenolate mofetil therapy Clinical Chemistry 48 517 525
10. Shaw LM Korecka M DeNofrio D Brayman KL 2001 Pharmacokinetic, pharmacodynamic, and outcome investigations as the basis for mycophenolic acid therapeutic drug monitoring in renal and heart transplant patients Clinical Biochemistry 34 17 22
11. Shaw LM Holt DW Oellerich M Meiser B van Gelder T 2001 Current issues in therapeutic drug monitoring of mycophenolic acid: report of a roundtable discussion Therapeutic Drug Monitoring 23 305 315
12. Weber LT Shipkova M Lamersdorf T et al. 1998 Pharmacokinetics of mycophenolic acid (MPA) and determinants of MPA free fraction in pediatric and adult renal transplant recipients Journal of the American Society of Nephrology 9 1511 1520
13. Weber LT Lamersdorf T Shipkova M et al. 1999 Area under the plasma concentration-time curve for total, but not for free, mycophenolic acid increases in the stable phase after renal transplantation: a longitudinal study in pediatric patients Therapeutic Drug Monitoring 21 498 506
14. Meier-Kriesche H-U Shaw LM Korecka M Kaplan B 2000 Pharmacokinetics of mycophenolic acid in renal insufficiency Therapeutic Drug Monitoring 22 27 30
15. Shaw LM Mick R Nowak I Korecka M Brayman KL 1998 Pharmacokinetics of mycophenolic acid in renal transplant patients with delayed graft function Journal of Clinical Pharmacology 38 268 275
16. Shaw LM Kaplan B DeNofrio D Korecka M Brayman KL 2000 Pharmacokinetics and concentration-control investigations of mycophenolic acid in adults after transplantation Therapeutic Drug Monitoring 22 14 19
17. Kuypers DRJ Claes K Evenepoel P Maes B Coosemans W Pirenne J Vanrenterghem Y 2003 Long-term changes in mycophenolic acid exposure in combination with tacrolimus and corticosteroids are dose dependent and not reflected by trough plasma concentration: a prospective study in 100 de novo renal allograft recipients Journal of Clinical Pharmacology 43 866 880
18. Kuypers DRJ Vanrenterghem Y Squifflet JP et al. 2003 Twelve-month evaluation of the clinical pharmacokinetics of total and free mycophenolic acid and its glucuronide metabolites in renal allograft recipients on low dose Tacrolimus in combination with mycophenolate mofetil Therapeutic Drug Monitoring 25 609 622
19. Tsina I Chu F Hama K Kaloostian M Tam YL Tarnowski T 1996 Manual and automated (robotnic) high-performance liquid chromatography methods for the determination of mycophenolic acid and its glucuronide conjugate in human plasma Journal of Chromatography. B, Biomedical Applications 675 119 129
20. Pawinski T Hale M Korecka M Fitzsimmons WE Shaw LM 2002 Limited sampling strategy for the estimation of mycophenolic acid area under the curve in adult renal transplant patients treated with concomitant tacrolimus Clinical Chemistry 48 1497 1504
21. van Gelder T Klupp J Barten MJ Christians U Morris RE 2001 Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid Therapeutic Drug Monitoring 23 119 128
22. Wollenberg K Krumme B Schollmeyer P Kirste G 1998 Pharmacokinetics of mycophenolic acid after renal transplantation Transplantation Proceedings 30 2237 2239
23. Shaw LM Nawrocki A Korecka M Solari S Kang J 2004 Using established immunosuppressant therapy effectively, lessons from the measurement of mycophenolic acid plasma concentrations Therapeutic Drug Monitoring 26 347 351
24. Cattaneo D Gaspari F Ferrari S et al. 2001 Pharmacokinetics help optimizing mycophenolate mofetil dosing in kidney transplant patients Clinical Transplantation 15 402 409
25. Mourad M Malaise J Eddour DCh de Meyer M König J Schepers R Squifflet JP 2001 Correlation of mycophenolic acid pharmacokinetic parameters with side effects in kidney transplant patients treated with mycophenolate mofetil Clinical Chemistry 47 88 94
26. Krumme B Wollenberg K Kirste G Schollmeyer P 1998 Drug monitoring of mycophenolic acid in the early period after renal transplantation Transplantation Proceedings 30 1773 1774
27. Pillans PI Rigby RJ Kubler P Willis Ch Salm P Tett SE Taylor PJ 2001 A retrospective analysis of mycophenolic acid and cyclosporine concentrations with acute rejection in renal transplant recipients Clinical Biochemistry 34 77 81
28. Oellerich M Shipkova M Schütz E Wieland E Weber L Tönshoff B Armtrong VW Members of the German Study Group on mycophenolate mofetil therapy in pediatric renal transplant recipients. 2000 Pharmacokinetic and metabolic investigations of mycophenolic acid in pediatric patients after renal transplantations for therapeutic drug monitoring Therapeutic Drug Monitoring 22 20 26
29. Pou L Brunet M Cantarell C et al. 2001 Mycophenolic acid plasma concentrations: influence of comedication Therapeutic Drug Monitoring 23 35 38